RMD Q3 2024 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q3 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.2B+7.2% YoY

Gross Profit

$682M56.9% margin

Operating Income

$375M31.3% margin

Net Income

$300M25.1% margin

EPS (Diluted)

$2.04

QoQ Revenue Growth

+2.9%

Cash Flow

Operating Cash Flow

$402M

Free Cash Flow

$379M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$6.8B

Total Liabilities

$2.2B

Stockholders' Equity

$4.6B

Cash & Equivalents

$238M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+7.2%
Gross Profit	$682M	$618M	+10.3%
Operating Income	$375M	$301M	+24.6%
Net Income	$300M	$233M	+29.2%

Revenue Segments

Sleep And Respiratory

$1.0B88%

Software As Service

$148M12%

Geographic Segments

Us Canada And Latin America

$687M57%

Combined Europe Asia And Other Markets

$362M30%

Sleep And Respiratory

$148M12%